Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Matinas Biopharma Holdings, Inc. (MTNB) had Normalized Income after Taxes of $-5.36M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-5.25M |
|
-- |
|
-- |
|
$1.84M |
|
$-1.84M |
|
$-3.41M |
|
$-5.25M |
|
$-5.36M |
|
$-5.25M |
|
$-5.25M |
|
$-5.25M |
|
|
Normalized Income after Taxes |
$-5.36M |
$-1.84M |
|
$-1.72M |
|
5.09M |
|
5.09M |
|
$-1.03 |
|
$-1.03 |
|
| Balance Sheet Financials | |
$7.27M |
|
$0.16M |
|
$4.16M |
|
$11.42M |
|
$1.78M |
|
$0.01M |
|
$1.97M |
|
$3.75M |
|
$7.67M |
|
$7.67M |
|
$7.67M |
|
5.09M |
|
| Cash Flow Statement Financials | |
$-4.03M |
|
-- |
|
$3.27M |
|
$7.53M |
|
$6.78M |
|
$-0.76M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.07 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-68.34% |
|
-68.34% |
|
-45.91% |
|
-68.24% |
|
$1.51 |
|
$-0.79 |
|
$-0.79 |
|